Changes in plasma lipids and apoproteins associated with physical training in middle-aged sedentary men. 1988

P Hespel, and P Lijnen, and R Fagard, and R Van Hoof, and M Rosseneu, and A Amery
Department of Pathophysiology, University of Leuven, Belgium.

The effect of endurance training on plasma lipoproteins was investigated in 27 healthy sedentary men between the ages of 20 and 55 years. During the first 4 months of the study, 13 of them (group A) participated in a training program (3 hours/wk), whereas the others served as control subjects (group B). At the end of this period the control subjects also underwent a 4-month training program. In both groups the training significantly increased physical working capacity at a heart rate of 130 bpm (PWC130), whereas it decreased the resting heart rate (p less than 0.05). Concomitantly with this improvement in cardiorespiratory fitness, a significant increase in the high-density lipoprotein (HDL) cholesterol concentration was observed (p less than 0.01); this was due to an increase in both HDL2 beta and HDL2 alpha + 3 cholesterol concentrations. The plasma total and HDL-apoprotein AI and apoprotein AII concentrations were not significantly affected by the training. Significant decreases in plasma triglyceride (p less than 0.05), very-low-density lipoprotein cholesterol (p less than 0.05), and low-density lipoprotein (LDL) cholesterol (p less than 0.001) concentrations were also observed, but only in group B, which showed a much greater increase in PWC130 at the end of the training period than group A; the decrease in the LDL cholesterol concentration in this group was accompanied by a slight decrease in the LDL-apoprotein B concentration.(ABSTRACT TRUNCATED AT 250 WORDS)

UI MeSH Term Description Entries
D008074 Lipoproteins Lipid-protein complexes involved in the transportation and metabolism of lipids in the body. They are spherical particles consisting of a hydrophobic core of TRIGLYCERIDES and CHOLESTEROL ESTERS surrounded by a layer of hydrophilic free CHOLESTEROL; PHOSPHOLIPIDS; and APOLIPOPROTEINS. Lipoproteins are classified by their varying buoyant density and sizes. Circulating Lipoproteins,Lipoprotein,Lipoproteins, Circulating
D008076 Cholesterol, HDL Cholesterol which is contained in or bound to high-density lipoproteins (HDL), including CHOLESTEROL ESTERS and free cholesterol. High Density Lipoprotein Cholesterol,Cholesterol, HDL2,Cholesterol, HDL3,HDL Cholesterol,HDL(2) Cholesterol,HDL(3) Cholesterol,HDL2 Cholesterol,HDL3 Cholesterol,alpha-Lipoprotein Cholesterol,Cholesterol, alpha-Lipoprotein,alpha Lipoprotein Cholesterol
D008078 Cholesterol, LDL Cholesterol which is contained in or bound to low density lipoproteins (LDL), including CHOLESTEROL ESTERS and free cholesterol. LDL Cholesterol,Cholesteryl Linoleate, LDL,LDL Cholesteryl Linoleate,Low Density Lipoprotein Cholesterol,beta-Lipoprotein Cholesterol,Cholesterol, beta-Lipoprotein,beta Lipoprotein Cholesterol
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010807 Physical Endurance The time span between the beginning of physical activity by an individual and the termination because of exhaustion. Endurance, Physical,Physical Stamina,Stamina, Physical
D002784 Cholesterol The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils. Epicholesterol
D005082 Physical Exertion Expenditure of energy during PHYSICAL ACTIVITY. Intensity of exertion may be measured by rate of OXYGEN CONSUMPTION; HEAT produced, or HEART RATE. Perceived exertion, a psychological measure of exertion, is included. Physical Effort,Effort, Physical,Efforts, Physical,Exertion, Physical,Exertions, Physical,Physical Efforts,Physical Exertions
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

P Hespel, and P Lijnen, and R Fagard, and R Van Hoof, and M Rosseneu, and A Amery
December 1969, Scandinavian journal of clinical and laboratory investigation,
P Hespel, and P Lijnen, and R Fagard, and R Van Hoof, and M Rosseneu, and A Amery
January 1970, Circulation,
P Hespel, and P Lijnen, and R Fagard, and R Van Hoof, and M Rosseneu, and A Amery
January 1982, Annals of clinical research,
P Hespel, and P Lijnen, and R Fagard, and R Van Hoof, and M Rosseneu, and A Amery
June 1980, European journal of clinical investigation,
P Hespel, and P Lijnen, and R Fagard, and R Van Hoof, and M Rosseneu, and A Amery
October 1988, Clinical physiology (Oxford, England),
P Hespel, and P Lijnen, and R Fagard, and R Van Hoof, and M Rosseneu, and A Amery
January 1979, Diabetes,
P Hespel, and P Lijnen, and R Fagard, and R Van Hoof, and M Rosseneu, and A Amery
February 1987, Circulation,
P Hespel, and P Lijnen, and R Fagard, and R Van Hoof, and M Rosseneu, and A Amery
January 1995, European journal of applied physiology and occupational physiology,
P Hespel, and P Lijnen, and R Fagard, and R Van Hoof, and M Rosseneu, and A Amery
December 1969, Scandinavian journal of clinical and laboratory investigation,
P Hespel, and P Lijnen, and R Fagard, and R Van Hoof, and M Rosseneu, and A Amery
September 1973, European journal of clinical investigation,
Copied contents to your clipboard!